SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: The Global Vaccine Market is Expected to Surpass Estimated USD 100 Billion By 2025

[January 27, 2014]

Research and Markets: The Global Vaccine Market is Expected to Surpass Estimated USD 100 Billion By 2025

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/2xtff6/global_vaccine) has announced the addition of the "Global Vaccine Market Pipeline Analysis" report to their offering.

The global vaccine market is characterized into human and animal vaccines. The segment of human vaccines is further sub-divided into four groups, namely pediatrics, adolescents, adults and elderly. Though the vaccines segment forms a very small portion of the global pharmaceutical drug sales (2-3%), the growth rate in this market has been extraordinary. This segment has grown at a high rate of 10-15% annually as compared to the overall pharmaceutical industry which grows at 5-7% per year.

The global market for vaccines is currently estimated to be worth more than US$ 30 Billion. With factors like advances in immunology, genetics and vaccine technology as well as incresed demand from population growth in emerging economies, the global vaccine market is expected to surpass estimated USD 100 billion by 2025.


"Global Vaccine Market Pipeline Analysis" gives a comprehensive insight on the various vaccines being developed across multiple indications. Research report covers all vaccines being developed in various clinical phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the global vaccines market based upon development process.

Following parameters for each drug profile in development phase are covered in "Global Vaccine Market Pipeline Analysis" research report:

- Drug Profile Overview

- Active Indication

- Phase of Development

- Country for Clinical Trial

- Owner / Originator/ Licensee/Collaborator

- Administrative Route

- Drug Class

- Patent Information

- Molecular Formula

- Brand Names

- Development Agreements

- ATC Codes

Number of Vaccines in Pipeline by Clinical Phase:

- Research: 110

- Preclinical: 378

- Clinical: 15

- Phase 0: 1

- Phase-I: 177

- Phase-I/II: 69

- Phase-II: 137

- Phase-II/III: 11

- Phase-III: 52

- Preregistration: 15

- Registered: 20

- Marketed: 156

- Unknown: 1

For more information visit http://www.researchandmarkets.com/research/2xtff6/global_vaccine

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.